Difference between revisions of "Pharm Tech Minutes 2015.02.24"

From IHE Wiki
Jump to: navigation, search
Line 46: Line 46:
  
  
=10:15 - 10:45 HMW Review=
+
=10:15 - 10:45 HMW Review, CMPD and HMW alignment with FHIR=
* Proposal
+
* Discussion
+
* Defining next steps
+
  
 +
Overview of the issues that we expected to find:
 +
* Functional model divergences (not really big, maybe no even significant, but must be analyzed)
 +
* Data model (mapping FHIR - CDA - V2) - this has already shown some gaps.
  
=10:45 - 11:15 FHIR topics=
+
'''Next steps:'''
 +
* Align with John Moehrke about a mechanism for collaboration.
 +
* Meanwhile, we can start providing some content for discussions with HL7 (on behalf of this mechanism).
 +
** Juergen will create a doodle for the next discussion.
  
 
=11:15 - 12:00 CMPD and HMW alignment with FHIR=
 
  
  
Line 62: Line 63:
 
=13:00 - 13:30 Preparation ITI, PCC, PHARM meeting=
 
=13:00 - 13:30 Preparation ITI, PCC, PHARM meeting=
 
* CP for duration of treatment
 
* CP for duration of treatment
 +
** Juergen presents the issue in the Duration of Treatment. in IHE, it is mandatory, even if null flavour.
 +
* Side question: Dosage instructions are including Route and Approach site. The problem with reviewing that is that the implementations have implemented it as is. This issue will be discussed later.
 +
* Resolution: CP makes sense as is, and it solves the problem without a need to discuss with PCC. Juergen will continue with this.
 +
 +
* Question on the Repeat/Duration: "Get a box of medication, get as many boxes as needed for 1 year" - is this repeat?
 +
** This issue can be resolved by the "duration of treatment", since each dispense is a partial dispense for a prescription, not a repeated dispense.
 +
The issue is that  sometimes we need to limit the amount of drug dispensed each time.
 +
 +
Leonidas: This is sometimes limited not by the amount, but by the time that is allowed to dispense
 +
Jacqueline: In France, the renewal possibility is linked to the type of drug. Some drugs may be renewed automatically, others cannot be renewed without a prescription.
 +
Action Item: Use Cases should be created to present the need for implementing any additional parameter like "maximum amount/time to dispense each time"
 +
'''Decision: Some text will be added to the DIS profile to clarify the use of Repeat'''
 +
Action item: A use case will be created to see if it breaks the current implementation (Stéphane)
  
  

Revision as of 07:36, 24 February 2015

Meeting details

Tuesday, 24 February 2015, 10:00 CET

Location : Villa Modigliani

  • PHARMA : salon Nabis
  • PCC : salon Baroques
  • QRPH : salon Fauves-Expressionnistes
  • ITI : salon Réalistes

WebEx details:

https://phastinternational.webex.com/phastinternational-en/j.php?MTID=m63d78e6130dbb440d12caf48205c9806

Meeting number: 958 500 452


JOIN BY PHONE

  • +33 17091 8646 France toll
  • 0800-9-19312 France toll free

Call-in Numbers: Global Call-in numbers

Access code: 958 500 452

10:00 - 10:15 Welcome

  • Participants
  • Michael Tan
  • Jose Costa Teixeira
  • Jürgen Brandstätter
  • Leonidas Tzimis
  • Simon Letellier
  • Jacqueline Surugue
  • Stephane Spahni
  • Isabelle Gibaud
  • Review and Approve Agenda
  • Approved
  • Approval of minutes of Technical Committee TCon on Jan 29
  • Approved


10:15 - 10:45 HMW Review, CMPD and HMW alignment with FHIR

Overview of the issues that we expected to find:

  • Functional model divergences (not really big, maybe no even significant, but must be analyzed)
  • Data model (mapping FHIR - CDA - V2) - this has already shown some gaps.

Next steps:

  • Align with John Moehrke about a mechanism for collaboration.
  • Meanwhile, we can start providing some content for discussions with HL7 (on behalf of this mechanism).
    • Juergen will create a doodle for the next discussion.


12:00 - 13:00 Lunch

13:00 - 13:30 Preparation ITI, PCC, PHARM meeting

  • CP for duration of treatment
    • Juergen presents the issue in the Duration of Treatment. in IHE, it is mandatory, even if null flavour.
  • Side question: Dosage instructions are including Route and Approach site. The problem with reviewing that is that the implementations have implemented it as is. This issue will be discussed later.
  • Resolution: CP makes sense as is, and it solves the problem without a need to discuss with PCC. Juergen will continue with this.
  • Question on the Repeat/Duration: "Get a box of medication, get as many boxes as needed for 1 year" - is this repeat?
    • This issue can be resolved by the "duration of treatment", since each dispense is a partial dispense for a prescription, not a repeated dispense.

The issue is that sometimes we need to limit the amount of drug dispensed each time.

Leonidas: This is sometimes limited not by the amount, but by the time that is allowed to dispense Jacqueline: In France, the renewal possibility is linked to the type of drug. Some drugs may be renewed automatically, others cannot be renewed without a prescription. Action Item: Use Cases should be created to present the need for implementing any additional parameter like "maximum amount/time to dispense each time" Decision: Some text will be added to the DIS profile to clarify the use of Repeat Action item: A use case will be created to see if it breaks the current implementation (Stéphane)


13:30 - 15:00 Supply of Healthcare Products

  • Process and method - White paper structure
    • Discuss with HL7 and ISO
  • Status and scope of White Paper
    • Discuss with IHE, HL7 and ISO


15:00 - 15:15 Break

15:15 - 16:15 Healthcare Products Catalogue

16:15 - 17:00 CPs on Community Pharmacy profiles

17:00 - 18:00 Medication Data overview

  • Overview of terms and concepts
  • Medication data collection
  • Defining next steps
  • Proposal
  • Defining next steps


18:00 Adjourn

Pharmacy Technical Committee